Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
Follow @Erowid on Instagram!
DEA Federal Register Entry
U.S. Federal register
Date="07/18/95" Citation="60 FR 36640" Group="legal" Type="RULE" Department="DEPARTMENT OF JUSTICE" Agency="DRUG ENFORCEMENT ADMINISTRATION (DEA), JUSTICE" Subject="Exemption of Agents and Employees; Affiliated Practitioners"
---- page 36640 ---- DEPARTMENT OF JUSTICE Drug Enforcement Administration 21 CFR Parts 1301 and 1306 [DEA No. 109F] RIN 1117-AA20 Exemption of Agents and Employees; Affiliated Practitioners AGENCY: Drug Enforcement Administration (DEA), Justice. ACTION: Final rule.
---- page 36640 ---- DEPARTMENT OF JUSTICE Drug Enforcement Administration 21 CFR Parts 1301 and 1306 [DEA No. 109F] RIN 1117-AA20 Exemption of Agents and Employees; Affiliated Practitioners AGENCY: Drug Enforcement Administration (DEA), Justice. ACTION: Final rule. + ------------------------------------------------------------ SUMMARY: DEA amends its regulations to allow for the exemption of agents and employees of a registered individual practitioner, hospital, or institution from the requirement for individual registration when administering, dispensing, or prescribing controlled substances in the course of their official duties or business. The amendments make the exemption granted to agents and employees of a registrant more consistent with the recent regulatory changes involving Mid-Level Practitioners (MLP) and the fee exemption for practitioners employed by Federal, state and local government hospitals or other institutions. DEA is also amending, without prior notice, its regulations concerning the manner of issuance of prescriptions to make the language of that section consistent with the amended language set forth herein. EFFECTIVE DATE: September 18, 1995. FOR FURTHER INFORMATION CONTACT: G. Thomas Gitchel, Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration, Washington, D.C. 20537, Telephone (202) 307-7297. SUPPLEMENTARY INFORMATION: On June 15, 1994, DEA published a Notice of Proposed Rulemaking (NPRM) in the Federal Register (59 FR 30738) proposing to amend the language under 21 CFR 1301.24 regarding the circumstances under which agents or employees of a DEA registrant may administer, dispense, or prescribe controlled substances in the course of their official duties or business without being required to obtain an individual registration. Specifically, sec 1301.24(b) was proposed to be amended to allow that an individual practitioner who acts as an agent or employee of another individual practitioner, other than a mid- level practitioner (MLP), may administer and dispense (other than by prescription) controlled substances in the normal course of his/her official duties or business under the registration of the employer or principal practitioner. Section 1301.24(c) was also proposed to be amended to allow an individual practitioner who is an agent or employee of a hospital or other institution to administer, dispense, or prescribe controlled substances under the registration of the hospital or other institution in lieu of becoming individually registered. The provisions outlined under sec 1301.24 (c)(1) through (c)(6) set forth the procedures under which an individual practitioner may administer, dispense and prescribe controlled substances utilizing the hospital or other institution's registration number. DEA received two written comments on the proposed amendments. The first commentor questioned whether the amended regulation would continue to allow hospital or institution residents and non-private practice staff physicians, in the course of inpatient and outpatient treatment of patients, to prescribe controlled substances under that hospital or institution's DEA registration number. The specific concern was with the potential financial impact on the institution if the proposed amendments required individual registration numbers for a hospital or institution's staff. The intent of the amendments is to expand the existing exemption from the registration requirement to include a greater population of practitioners. The language of sec 1301.24(c) deletes the restriction of an individual practitioner "who is an intern, resident, mid-level practitioner, etc.'' and replaces that language with "[a]n individual practitioner''. The amendments will not affect the authority of those individual practitioners, i.e., interns, residents, mid-level practitioners, foreign trained physicians, etc., already authorized to dispense controlled substances under a hospital or institution registration number. The first commentor additionally wished to ensure that prescriptions issued by agents or employees of a registered hospital or institution would be valid at community pharmacies in the event that patients choose not to use the prescribing institution's pharmacy. Prescriptions issued by agents or employees, consistent with the exemption, are legitimate prescriptions that may be filled at any local registered pharmacy. The regulations do not restrict dispensing of prescriptions to the prescribing hospital or institution. The second commentor raised three separate concerns. The first inquired as to who has the oversight responsibility for determining whether a given agent or employee, while operating in the usual course of his/her duties, is authorized to handle controlled substances in the jurisdiction in which the registrant practices. The responsibility for determining whether a registrant's agents and/or employees are authorized by state law to handle controlled substances lies with the registrant. As a threshold matter, DEA cannot register an applicant to handle controlled substances unless that individual practitioner, hospital or other institution has the necessary state authorization or permission to engage in such activities. DEA registration does not convey to a practitioner, hospital or institution any specific authority or permission to engage in controlled substances activities beyond such state authority. Title 21 CFR 1307.02 states "Nothing in parts 1301-1308, 1311, 1312, or 1316 of this chapter shall be construed as authorizing or permitting any person to do any act which such person is not authorized or permitted to do under other Federal laws or obligations under international treaties, conventions or protocols, or under the law of the State in which he desires to do such act nor shall compliance with such parts be construed as compliance with other Federal or State laws unless expressly provided in such other laws.'' DEA registrants are responsible for ensuring that any controlled substance activities carried out pursuant to their DEA registrations are in full compliance with all applicable Federal and State laws governing controlled substances. Section 1301.24(c)(3) spells out the requirement that a hospital or other institution must verify that individual practitioners who will administer, dispense or prescribe controlled substances under the facility's registration, are authorized to do so under state law. If a controlled substances activity is not authorized or permitted under other Federal or State laws, then the registrant may not allow the activity to be carried out under its registration. The second commentor also expressed concern with a perceived inconsistency in the language set forth in sec 1301.24(c) introductory text and, by reference, in sec 1301.24(c)(5), in that paragraph (c) introductory text permits the individual practitioner to "administer, dispense or prescribe'' under the hospital registration, but paragraph (c)(5) requires only that the registered hospital authorize such practitioner to "dispense or prescribe''. The technical definition of dispense, as set forth in 21 U.S.C. 802(10), includes the administration of a controlled substance; therefore, an individual ---- page 36641 ---- practitioner authorized to dispense a controlled substance would also be authorized to administer a controlled substance. However, in order to avoid further confusion and to maintain consistency, paragraph (c)(5) will be amended to read "administer, dispense or prescribe.'' The second commentor additionally requested that DEA provide estimates of any financial or other impact on affected entities, including any increased risk or liability. With regard to this request, it must be noted that the provisions set forth under sec 1301.24 are not mandatory. If an individual practitioner, hospital or other institution chooses to use the exemptions, however, it is that registrant's responsibility to assess any potential benefits, as well as any risks or liabilities and determine whether the advantages outweigh the disadvantages in using the exemption provisions. DEA is also amending the language of sec 1306.05(b) without prior notice, in order to make the language of that section consistent with the new language in sec 1301.24(c). Section 1306.05(b) relates to the manner of issuance of prescriptions issued by persons exempted from the registration requirement under sec 1301.24(c). The language is being amended by deleting the reference to "An intern, resident, or foreign-trained physician, or physician on the staff of a Veterans Administration facility, * * *'' and inserting "An individual practitioner * * * '' The Deputy Assistant Administrator, Office of Diversion Control, hereby certifies that this rulemaking will have no significant impact upon entities whose interests must be considered under the Regulatory Flexibility Act, 5 U.S.C. 601 et seq. This final rule expands an existing exception to the registration requirements to provide regulatory relief to a greater population of practitioners. This final rule is not a significant regulatory action and therefore has not been reviewed by the Office of Management and Budget pursuant to Executive Order 12866. This action has been analyzed in accordance with the principles and criteria in Executive Order 12612, and it has been determined that the final rule does not have sufficient federalism implications to warrant the preparation of a Federalism Assessment. List of Subjects 21 CFR Part 1301 Administrative practice and procedure, Drug traffic control, Security measures. 21 CFR Part 1306 Drug traffic control, Prescription drugs. For reasons set out above, 21 CFR part 1301 is amended as follows: PART 1301-[AMENDED] 1. The authority citation for part 1301 continues to read as follows: Authority: 21 U.S.C. 821, 822, 823, 824, 871(b), 875, 877. 2. Section 1301.24 is amended by revising paragraphs (b), (c) introductory text and (c)(5) to read as follows: sec 1301.24 Exemption of agents and employees; affiliated practitioners. * * * * * (b) An individual practitioner, as defined in section 1304.02 of this chapter, who is an agent or employee of another individual practitioner (other than a mid-level practitioner) registered to dispense controlled substances may, when acting in the normal course of business or employment, administer or dispense (other than by issuance of prescription) controlled substances if and to the extent that such individual practitioner is authorized or permitted to do so by the jurisdiction in which he or she practices, under the registration of the employer or principal practitioner in lieu of being registered him/herself. (c) An individual practitioner, as defined in sec 1304.02 of this chapter, who is an agent or employee of a hospital or other institution may, when acting in the normal course of business or employment, administer, dispense, or prescribe controlled substances under the registration of the hospital or other institution which is registered in lieu of being registered him/herself, provided that: * * * * * (5) The hospital or other institution authorizes the individual practitioner to administer, dispense or prescribe under the hospital registration and designates a specific internal code number for each individual practitioner so authorized. The code number shall consist of numbers, letters, or a combination thereof and shall be a suffix to the institution's DEA registration number, preceded by a hyphen (e.g., AP0123456-10 or AP0123456- A12); and * * * * * PART 1306 [AMENDED] 1. The authority citation for part 1306 continues to read as follows: Authority: 21 U.S.C. 821, 829, 871(b), unless otherwise noted. 2. Section 1306.05 is amended by revising paragraph (b) to read as follows: sec 1306.05 Manner of issuance of prescriptions. * * * * * (b) An individual practitioner exempted from registration under sec 1301.24(c) of this chapter shall include on all prescriptions issued by him or her the registration number of the hospital or other institution and the special internal code number assigned to him or her by the hospital or other institution as provided in sec 1301.24(c) of this chapter, in lieu of the registration number of the practitioner required by this section. Each written prescription shall have the name of the physician stamped, typed, or handprinted on it, as well as the signature of the physician. * * * * * Dated: June 16, 1995. Gene R. Haislip, Deputy Assistant Administrator, Office of Diversion Control. [FR Doc. 95-17515 Filed 7-17-95; 8:45 am] BILLING CODE 4410-09-M ------------------------------------------------------ The Contents entry for this article reads as follows: Manufacturers, distributors, and dispensers of controlled substances; registration, etc.: Agents and employees, exemptions; affiliated practitioners, 36640
.